Georgia's Online Cancer Information Center

Georgia Cancer Center receives $6 million grant to improve access to clinical trials




AUGUSTA, Ga. (Sept. 12, 2019) - The Georgia Cancer Center at Augusta University has been awarded a six-year $6 million grant from the National Cancer Institute (NCI) to lead a statewide initiative that improves access to innovative clinical trials for a variety of cancers to underserved individuals across Georgia.

As one of 14 NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites nationally, the Georgia Cancer Center's Georgia CaRES (Georgia Cancer Research) network will use the money to recruit patients to conduct multi-site cancer clinical trials and cancer care delivery studies in the patients' communities.

"We are very excited to get this award at a higher level of funding as it allows us to take cutting-edge cancer care across rural Georgia," said Dr. Sharad Ghamande, associate director for clinical trials at the Georgia Cancer Center. "This will allow us to build on our success in our previous grant (2014-19), where 49% of our patients accrued to clinical trials were minorities."

While discoveries start in a basic science lab, clinical trials are where the laboratory findings are translated to see how they can improve the treatment of cancer in patients. Clinical trials offer patients not only the standard of care chemotherapy but also the possibility of receiving treatment that could be more beneficial in the future. According to the NCI, the overall goal of NCORP is to bring cancer clinical research studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities. Cancer care delivery studies look at the success and cost-efficiency of current cancer care practices.

The 49% enrollment for patients in Georgia is a big increase over the national enrollment percentages. Research shows only 1 out of 20 cancer patients enroll in clinical trials. Of those patients, less than 5 percent are minorities. Because clinical trials are more commonly used to treat children with cancer, survival rates for childhood cancer have increased dramatically in the last few decades.

Ghamande, who serves as the principal investigator for the grant, will work with a team at the Georgia Cancer Center and partner sites across Georgia as well as one site in Mississippi. Partners include the University Cancer and Blood Center (Athens), Augusta Oncology Associates (Augusta), Morehouse School of Medicine (Atlanta), Phoebe Putney Memorial Hospital (Albany) and St. Dominic-Jackson Memorial Hospital (Jackson, Mississippi) which has a minority and rural population similar to what we see in Georgia.

"The awarding of this grant is a recognition of the efforts of Dr. Ghamande and the commitment of the Georgia Cancer Center to improve cancer care in our communities," said Dr. Jorge Cortes, director of the Georgia Cancer Center. "There has been tremendous progress in our fight against cancer. Unfortunately, many patients do not have access to the most advanced therapies and clinical trials. By extending the participation in clinical trials of underserved and minority populations in Georgia and Mississippi through this grant, we can improve their long-term outlook."



Media Contact

Chris Curry



View More

Media, News & Events

New ASCO COVID-19 Registry Aims to Understand Impact on Patients During Pandemic, Inform Future Care

Last week, the American Society of Clinical Oncology (ASCO) launched the ASCO Survey on COVID-19 in Oncology Registry.

 Research 4/20/2020

Coping with Metastatic Triple Negative Breast Cancer

  • Updates on the Treatment of Metastatic Triple Negative Breast Cancer, in the Context of COVID-19
  • Novel Treatment Approaches
  • Clinical Trial Updates
  • How Research Offers More Treatment Options
  • Diagnostic Testing and Technologies: Why They Are So Important
  • The Role of Precision Medicine in Improving Treatment Decisions
  • Tips to Cope with & Control Symptoms, Side Effects & Pain
  • Guidelines to Prepare for Telehealth/

Georgia CORE and partners win five-year grant for colorectal cancer prevention

The CDC-funded program will bring colorectal screening, navigation and colonoscopies to 15,000 people in southeast and southwest Georgia.

Comparing Community Practice Data in Georgia with the South and U.S.

Georgia CORE's Dr. Hamrick breaks down national data on how COVID-19 has been impacting cancer care in Georgia.

 Media & Events 6/25/2020

How the Georgia Sewers came to the rescue

Nearly 400 volunteers in 58 counties have been cutting out fabric and elastic, handling administrative duties and of course, sewing.

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.